GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Shanghai INT Medical Instruments Co Ltd (HKSE:01501) » Definitions » Cash per Share

Shanghai INT Medical Instruments Co (HKSE:01501) Cash per Share : HK$2.26 (As of Jun. 2024)


View and export this data going back to 2019. Start your Free Trial

What is Shanghai INT Medical Instruments Co Cash per Share?

Cash per Share is calculated as Cash, Cash Equivalents, Marketable Securities divided by Shares Outstanding (EOP). Shanghai INT Medical Instruments Co's Cash per Share for the quarter that ended in Jun. 2024 was HK$2.26.


Shanghai INT Medical Instruments Co Cash per Share Historical Data

The historical data trend for Shanghai INT Medical Instruments Co's Cash per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shanghai INT Medical Instruments Co Cash per Share Chart

Shanghai INT Medical Instruments Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cash per Share
Get a 7-Day Free Trial Premium Member Only 6.21 4.73 3.51 2.79 3.40

Shanghai INT Medical Instruments Co Semi-Annual Data
Dec16 Dec17 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Cash per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.51 3.05 2.79 2.26 3.40

Shanghai INT Medical Instruments Co Cash per Share Calculation

This is the ratio of a company's available cash, including easy to liquidate short-term investment, to its total number of shares outstanding. The result indicates the percentage of a company's share price that is available to spend on company's activities, such as strengthening the business, paying down the debt and making dividend payment to shareholders. It's a reliable indicator of a company's financial health.

Shanghai INT Medical Instruments Co's Cash per Share for the fiscal year that ended in Dec. 2023 is calculated as:

Shanghai INT Medical Instruments Co's Cash per Share for the quarter that ended in Jun. 2024 is calculated as:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Shanghai INT Medical Instruments Co  (HKSE:01501) Cash per Share Explanation

Cash per Share represents the liquidity of a compant's assets. A high level of Cash per Share suggests that there's enough money on hand for a company to cover any emergencies and that the company has adequate money to reinvest its business or pay dividends to investors. However, if the ratio is too high, it can also suggeust the inefficiency of management for not making a full usage of the cash.


Shanghai INT Medical Instruments Co Cash per Share Related Terms

Thank you for viewing the detailed overview of Shanghai INT Medical Instruments Co's Cash per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Shanghai INT Medical Instruments Co Business Description

Traded in Other Exchanges
N/A
Address
No. 925 Jin Yuan Yi Road, Block 2, Jiading District, Shanghai, CHN, 201803
Shanghai INT Medical Instruments Co Ltd engages in the design and development of medical devices used in fields including peripheral intervention, neurological intervention, cardiovascular intervention or implantation and the design and development of equipment and moulds used for the production of medical devices. The company operates in the Chinese Mainland, Europe, The United States and Other countries and regions. The majority of revenue is from the Chinese Mainland.
Executives
China Orient Asset Management (international) Holding Limited 2201 Interest of corporation controlled by you
Zhao Wei 2202 Interest of your spouse
Wang Kai 2201 Interest of corporation controlled by you
Ningbo Huaige Taiyi Equity Investment Partnership (limited Partnership) 2101 Beneficial owner
Ningbo Huaige Health Investment Management Partnership (limited Partnership) 2201 Interest of corporation controlled by you
Ningbo Huaige Gongxin Equity Investment Partnership (limited Partnership) 2201 Interest of corporation controlled by you
Central Huijin Investment Ltd. 2201 Interest of corporation controlled by you
Jpmorgan Chase & Co. 2106 Person having a security interest in shares
Orbimed Capital Llc 2102 Investment manager
Zhao Wei 2202 Interest of your spouse
Zheng Aiping 2501 Other
Zhang Xianmiao 2501 Other
Zhang Wei 2501 Other
Shanghai Kindly Holding Group Co., Ltd. 2201 Interest of corporation controlled by you
Shanghai Kindly Enterprise Development Group Co., Ltd. 2101 Beneficial owner

Shanghai INT Medical Instruments Co Headlines

No Headlines